An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Matching Software Market Size, Share & Trends Analysis Report by Deployment Mode (Web & Cloud-based, on-premise), End Use (Pharmaceutical ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. As longtime cancer doctors with regulatory experience, ...

Randomized controlled trials remain the most effective tool in the pharmaceutical industry’s evidence-generation toolkit. They are crucial for demonstrating novel drugs' safety and efficacy, assessing ...